Exelixis Announces EMA Acceptance of ...

Exelixis Announces EMA Acceptance of Marketing Authorization...

There are 2 comments on the Freshnews story from Nov 29, 2012, titled Exelixis Announces EMA Acceptance of Marketing Authorization.... In it, Freshnews reports that:

Exelixis, Inc. today announced the European Medicines Agency has accepted for review the Marketing Authorization Application for COMETRIQ for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer .

Join the discussion below, or Read more at Freshnews.

dailyrx

Austin, TX

#1 Nov 30, 2012
Looking for more information on Cometriq? Here's a pharmacist's description: http://www.rxwiki.com/cometriq
jenas1

San Jose, CA

#2 Dec 13, 2012
We don't have the time to keep up with the current marketing trends. We are looking for a marketing firm grand rapids who is forward thinking. Any recommendations?

http://deksia.com/

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Healthcare Law Discussions

Title Updated Last By Comments
News Lawmakers revisiting requiring those on Medicai... 36 min Retribution 19
News APNewsBreak: Problems remain at troubled Washin... 1 hr CodeTalker 1
News After three days the South Carolina Senate leav... 11 hr Lady Rivera 1
News Nurse anesthetists aren't the same as anesthesi... (Sep '10) 12 hr Stanley 143
Any side effects while on Chantix? (Jul '07) 14 hr Keith sluder 1,745
News Community activities, meetings (Jul '09) Fri Grandparent in Mi... 5
Chantix dosage - 2mg to start off? (Sep '07) Apr 20 RCKilgore 50
More from around the web